These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35534516)

  • 1. Estimating and explaining cross-country variation in the effectiveness of non-pharmaceutical interventions during COVID-19.
    Banholzer N; Feuerriegel S; Vach W
    Sci Rep; 2022 May; 12(1):7526. PubMed ID: 35534516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave.
    Banholzer N; van Weenen E; Lison A; Cenedese A; Seeliger A; Kratzwald B; Tschernutter D; Salles JP; Bottrighi P; Lehtinen S; Feuerriegel S; Vach W
    PLoS One; 2021; 16(6):e0252827. PubMed ID: 34077448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
    Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M
    BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries.
    Mader S; Rüttenauer T
    Front Public Health; 2022; 10():820642. PubMed ID: 35444988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessing the syndemic of COVID-19 and malaria intervention in Africa.
    Shi B; Zheng J; Xia S; Lin S; Wang X; Liu Y; Zhou XN; Liu J
    Infect Dis Poverty; 2021 Jan; 10(1):5. PubMed ID: 33413680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories.
    Ge Y; Zhang WB; Wu X; Ruktanonchai CW; Liu H; Wang J; Song Y; Liu M; Yan W; Yang J; Cleary E; Qader SH; Atuhaire F; Ruktanonchai NW; Tatem AJ; Lai S
    Nat Commun; 2022 Jun; 13(1):3106. PubMed ID: 35661759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Perceptions and Attitudes Toward COVID-19 Nonpharmaceutical Interventions Across Six Countries: A Topic Modeling Analysis of Twitter Data.
    Doogan C; Buntine W; Linger H; Brunt S
    J Med Internet Res; 2020 Sep; 22(9):e21419. PubMed ID: 32784190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa.
    Kilonzo CM; Wamalwa M; Whegang SY; Tonnang HEZ
    BMC Res Notes; 2022 Sep; 15(1):283. PubMed ID: 36059028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferring the effectiveness of government interventions against COVID-19.
    Brauner JM; Mindermann S; Sharma M; Johnston D; Salvatier J; Gavenčiak T; Stephenson AB; Leech G; Altman G; Mikulik V; Norman AJ; Monrad JT; Besiroglu T; Ge H; Hartwick MA; Teh YW; Chindelevitch L; Gal Y; Kulveit J
    Science; 2021 Feb; 371(6531):. PubMed ID: 33323424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Kohanovski I; Obolski U; Ram Y
    Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.
    Regmi K; Lwin CM
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis.
    Summan A; Nandi A
    Eur J Health Econ; 2022 Feb; 23(1):105-117. PubMed ID: 34304325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: A global experience.
    Liang LL; Kao CT; Ho HJ; Wu CY
    J Glob Health; 2021; 11():05021. PubMed ID: 34552726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
    Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
    Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.
    ÓhAiseadha C; Quinn GA; Connolly R; Wilson A; Connolly M; Soon W; Hynds P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Artificial Intelligence to assess the impact of nonpharmaceutical interventions on the second wave of the Coronavirus Disease 2019 pandemic across the world.
    Tao S; Bragazzi NL; Wu J; Mellado B; Kong JD
    Sci Rep; 2022 Jan; 12(1):944. PubMed ID: 35042945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021.
    García-García D; Herranz-Hernández R; Rojas-Benedicto A; León-Gómez I; Larrauri A; Peñuelas M; Guerrero-Vadillo M; Ramis R; Gómez-Barroso D
    Euro Surveill; 2022 May; 27(19):. PubMed ID: 35551707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19.
    Bendavid E; Oh C; Bhattacharya J; Ioannidis JPA
    Eur J Clin Invest; 2021 Apr; 51(4):e13484. PubMed ID: 33400268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.